Market Cap
3252429.00
GRTX
Galera Therapeutics, Inc.
Exchange: nyse
Multiples
- P/E: -0.17
- P/BV: -0.02
- P/TBV: -0.02
Description:
GRTX refers to Gritstone Oncology Inc., a biotechnology company listed on the New York Stock Exchange (NYSE). The company focuses on the development of personalized cancer immunotherapies aimed at treating solid tumors by leveraging its knowledge in neoantigen selection and presentation. Gritstone Oncology aims to improve patient outcomes through its innovative approaches in immuno-oncology, making significant strides in the field of cancer treatment.
Data:
Yields:
